Author Archives: corekev

Diabetes is the most common endocrine disorder. It is a globally spread public health concern that has potentially serious consequences. A person with Diabetes undergoes spikes in blood sugar levels, and these spikes can sometimes reach life-threatening levels.  Diabetes is categorized into the following types: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, and Prediabetes.Continue reading “Diabetes: What It Is, Treatment Options, and Key Companies”

The pharmaceutical market is ever-changing. To thrive in such a market, it is crucial to be aware of the constant developments happening in this industry that impact one’s business. Moreover, there is fierce competition between pharmaceutical firms to strengthen their pipelines due to patent expiration, rapid innovation, and changing patient needs. Hence, in such aContinue reading “Pharmaceutical Competitive Intelligence: A Reliable Tool For An Ever-Changing Market”

In this list, we mention the top 5 rare disease-based articles that are a must-read for anyone interested in the life science field. Find out in detail about these diseases, what causes them, and how they are treated presently. Hemophilia: The Evolved Gene Therapy for Hemophilia Hemophilia is a rare inherited disease in which bloodContinue reading “Five Important Developments In The Rare Disease Treatment Market”

Being overweight (Obesity) can easily be averted, and yet almost one-third of the adult population suffers from this condition globally. In the year 2020, studies showed that approximately 39 million children below 5, around the world, were either obese or overweight. While childhood obesity is not unhealthy, it needs to be managed in adulthood. ObesityContinue reading “What Companies Around The World Provide Solutions To Obesity?”

From Leading Pharmaceutical Markets to Applications of Robots in Healthcare, from wearable drugs to femtech markets, these are the trending articles of this year that are a must-read for people from in and around the healthcare industry. Which Countries Top the Chart in the Global Pharmaceutical Market? The Pharmaceutical industry was born in the nineteenthContinue reading “DelveInsight’s Ten Must Read Pharmaceutical Industry-based Articles”

Hemophilia is a disorder in which the person affected cannot stop bleeding after undergoing an injury. Hemophilia is a rare genetic disorder that leads to the person lacking clotting factors (blood-clotting proteins) in their blood. This causes a disturbance in the natural blood clotting process. Patients with acute forms of Hemophilia display spontaneous bleeding atContinue reading “What Are The Benefits And Drawbacks Of Gene Therapy In Hemophilia?”

IgA Nephropathy is tough to diagnose due to its nature. It occurs mostly in a minor, heterogeneous, and widely scattered set of patients. Thus, the replication, design, and study enrollment of IgA Nephropathy in clinical trials is filled with complications. As a result, substantial losses have to be sustained because of a general delay inContinue reading “What is IgA Nephropathy? A Brief Introduction On The Renal Condition”

With the power to modify the healthcare system, smart hospitals dispense a range of benefits to both the patients and healthcare providers. A smart hospital streamlines the communication process, caters to the many needs of healthcare providers, improves the patient’s relationship, and maintains costs. Correspondingly, a patient too, undergoes a smooth treatment journey, beginning rightContinue reading “Smart Hospitals And Their Impacts On Healthcare Systems”

With each year that unfolds, a list of novel approved medications is added for treating multitudes of disorders and illnesses that affect humanity. This year was no different. But due to the COVID-19 outbreak, the general population is now more aware of the upcoming drugs and their applications. With a noteworthy response to the worldwideContinue reading “Crucial Drugs Launched In The First Half Of 2021: A Brief Introduction”

In 1981, the first incidence of HIV was recorded. In March 1987, six years after the first incidence, the US FDA approved the earliest drug for treating AIDS. This drug was called zidovudine (azidothymidine). Fast forward to today, and the treatment options for HIV are diverse and comprise several classes of drugs. The remarkable evolutionContinue reading “HIV-1 Treatment Market: Factors Responsible For The Changing Dynamics”